Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752.
MET 扩增可能识别出对选择性酪氨酸激酶抑制剂 PHA-665752 极其敏感的癌症亚群
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.0508776103
Smolen Gromoslaw A, Sordella Raffaella, Muir Beth, Mohapatra Gayatry, Barmettler Anne, Archibald Heidi, Kim Woo J, Okimoto Ross A, Bell Daphne W, Sgroi Dennis C, Christensen James G, Settleman Jeffrey, Haber Daniel A